Introduction

Preclinical testing plays a vital role in transforming new molecules into safe, effective medicines. At Accuprec Research Labs, we are committed to supporting pharmaceutical innovations with our comprehensive range of toxicological and preclinical testing services, helping our clients meet global regulatory requirements and bring safer drugs to market faster.

Why Preclinical Testing is Important

• Establishes safety profiles before human trials
• Identifies potential toxicity and adverse effects
• Ensures compliance with GLP, OECD, and international standards
• Provides critical data for regulatory submissions

Accuprec’s Capabilities

Our preclinical facility offers a wide range of GLP-compliant studies, including:

• Acute, sub-acute, and chronic toxicity studies
• Local tolerance and irritation studies
• Genotoxicity and reproductive toxicity assessments
• Safety pharmacology and dose-ranging studies
• Toxicokinetic evaluations

Facilities & Expertise

• AAALAC-accredited animal facilities ensuring ethical research practices
• OECD GLP-certified infrastructure for reliable and reproducible data
• Highly experienced toxicologists and pathologists
• Comprehensive analytical support with LC-MS/MS, GC-MS/MS, and ICP-MS

Regulatory Compliance

Our preclinical studies align with the following regulatory frameworks:

• OECD GLP Guidelines
• FDA and EMA Preclinical Testing Requirements
• Schedule Y (CDSCO India)

Meet Us at CPHI Frankfurt 2025

Join Accuprec at Stall D96 | Hall 6.1 at Messe Frankfurt, Germany, to explore our world-class toxicological and preclinical testing services that ensure global compliance and product safety.